Controversy Surrounding New Zealand's E-Cigarette Quit Smoking Program

Jan.02
Controversy Surrounding New Zealand's E-Cigarette Quit Smoking Program
New Zealand Health Ministry to provide e-cigarette starter kits to aid adult smoking cessation, drawing criticism from health advocates.

According to NZ Herald on January 2nd, Casey Costello, the Deputy Minister of Health in New Zealand, announced that starting next week, e-cigarette starter kits will be provided to smoking cessation services nationwide to assist adults in quitting smoking. However, this move has been criticized by health advocates.


Letitia Harding, CEO of the Asthma and Respiratory Foundation, expressed concerns about the controversial practice of using e-cigarettes to quit smoking.


These products have not yet been approved for smoking cessation by the World Health Organization, the FDA (U.S. Food and Drug Administration), or the New Zealand Medicines and Medical Devices Safety Authority (Medsafe). Therefore, distributing these medications as therapeutic products without going through proper rigorous consultation procedures is truly bizarre. They are set to launch this plan next week, which seems too insane.


Harding noted that the plan lacks details and simply involves moving people from one product to another without a clear exit strategy.


Which products will actually receive funding, and how will they actually break free from long-term nicotine dependence on e-cigarette products? In the next decade or few decades, we may see a "New Zealand without e-cigarettes.


Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.